Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C - sprookjes - yvandenbroek - TriplyDB

Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

http://www.wikidata.org/entity/Q24200197

about

Pharmacological treatments for chronic hepatitis C liver disease: a network meta-analysis Aminoadamantanes for chronic hepatitis C Nitazoxanide for chronic hepatitis C Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C.Ophthalmological side effects of interferon therapy of chronic hepatitis C.Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus.

P2860

Q24186846-1582631B-F7CC-4177-B638-74D2D710191B Q24194770-522F81F5-175D-4972-9421-7DC88F002DFC Q24197485-F9A700D5-AA0E-4D4B-B4F1-2F8B476C0777 Q24200189-771F7534-5449-49F1-8D58-4C2CB21B407E Q36203547-48BD2E91-51EF-4D46-AE37-C69697EDB61A Q36924886-64B93A39-C11F-4B64-A2CA-9A6FC5656524 Q44666957-96EDCEEF-6799-4348-AB0A-2BF58D25FBF2

P2860

Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

http://www.wikidata.org/entity/Q24200197

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

@ast

Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

@en

Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

@en-gb

Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

@nl

type

label

Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

@ast

Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

@en

Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

@en-gb

Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

@nl

prefLabel

Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

@ast

Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

@en

Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

@en-gb

Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

@nl

P1433

Q24200197-D7A8D669-1931-4931-9005-B242E6613736

P1476

Q24200197-484FE003-E72D-4AA9-AB8D-AEB6CFAE4B40

P2093

Q24200197-38A415FC-EF34-44DA-90C6-F0C2C2252E1D

P2860

Q24200197-04E277FF-E28C-4F0E-9863-1062EF2567AA

Q24200197-068A93B1-798D-4F13-8098-890B6ED98BC9

Q24200197-06F804FF-AFB1-4654-A493-D6237BA9A4E9

Q24200197-08E7729E-2F6A-425E-B3E8-95107CE3E56C

Q24200197-0AD094AA-0BA5-4F7B-8035-3C1DB8801641

Q24200197-0CDD8EFC-90AF-4B50-AB28-132EFF669B7F

Q24200197-0F3AA61B-1B0B-40E8-BF58-69C9CBA61314

Q24200197-119C72AB-1242-45C4-B3E8-8F5F1712475A

Q24200197-168364D5-6496-4128-866C-36CA31558761

Q24200197-1B58E215-D00E-40A9-B95C-D8AC9DCD732C

P304

Q24200197-DE15FFF3-B60B-4A4D-8D45-06B58328A1EE

P31

Q24200197-1995b93d-ec72-4ebc-b211-acb7e6bb0a75

Q24200197-65522A0B-A92B-4810-AE72-0A5DF92A1893

P356

Q24200197-7E922A7D-C1DF-47EE-AD91-C7D3AE17E45E

P433

Q24200197-863480D9-A901-4275-8DFA-31FE787B94E9

P50

Q24200197-1E78EA66-09C8-428C-916D-BD996E134F6C

Q24200197-1ECABB2C-8963-474F-B78A-71D5CB1C3AE9

Q24200197-82DA2E13-830F-4D9A-8CD8-D649F317B95B

Q24200197-B74409A7-8A82-453C-BFF6-B3A2FA16EBC3

Q24200197-D793E124-F636-4B31-A83C-6E29BDC41888

P577

Q24200197-03F26A70-E799-4D9D-8FAB-4763B368D5EE

P698

Q24200197-56AA2682-D2E0-4A74-B14D-153EF3DBA88D

P356

14651858.CD005642.PUB3

P1433

Cochrane Database of Systematic Reviews

P1476

Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

@en

P2093

Kristian Thorlund

http://www.w3.org/2001/XMLSchema#string

P2860

Why most published research findings are false

Publication of clinical trials supporting successful new drug applications: a literature analysis

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

Industry sponsorship and research outcome

Pegylated interferon alpha 2a versus pegylated interferon alpha 2b for chronic hepatitis C

Publication bias in clinical trials due to statistical significance or direction of trial results

Ribavirin plus interferon versus interferon for chronic hepatitis C

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

What is meant by intention to treat analysis? Survey of published randomised controlled trials

P304

CD005642

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD005642.PUB3

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P50

Christian Gluud

Mahasen Mabrouk

P577

2014-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24585451

http://www.w3.org/2001/XMLSchema#string